Lupus & antiphospholipid syndrome

The impact of disease activity and interferon-α on the nervous system in systemic lupus erythematosus

Arthritis Res TherPublished Cross-sectional study with retrospective longitudinal data

Main finding · More cognitive dysfunctionResult — go to the resultOdds ratio 11.0

Authors' conclusion

The study suggests that disease activity and IFN-α may drive neuronal affliction in SLE, also in the absence of overt neuropsychiatric symptoms

Study context

Population
Consecutive female systemic lupus erythematosus (SLE) outpatients, Lund Lupus Cohort
Participants
24 / 33 / 31 / 35
Exposure
High vs low interferon (IFN)-α lupus phenotype; moderate-high vs low SLEDAI-2K lupus phenotype
  • High IFN-αn = 24
  • Low IFN-αn = 33reference
  • Moderate-high SLEDAI-2 Kn = 31
  • Low SLEDAI-2 Kn = 35reference
Outcome
Neuronal impairment: plasma NfL concentrations, structural magnet resonance imaging (MRI) alterations, and cognitive dysfunction (CNS-Vital Signs)
Methodological detailsconsecutive outpatients, multivariate linear mixed-effect, linear and logistic regression models
  • Consecutive outpatients
  • Multivariate linear mixed-effect, linear and logistic regression models

Main finding

More cognitive dysfunction

Odds ratio

11.0

P = 0.004

As reported in the abstract

Visits with higher disease activity associated with higher plasma neurofilament light (NfL) concentrations (SLEDAI-2K total)
P = 1.5*10- 6
High vs low IFN-α: smaller total grey matter volume
P = 0.036
High vs low IFN-α: smaller caudate nucleus volume
P = 0.038
High vs low IFN-α: smaller thalamus volume
P = 0.023
Moderate-high vs low SLEDAI-2K: larger white matter lesion volumes
P = 0.011
Moderate-high vs low SLEDAI-2K: smaller total grey matter volume
P = 0.041
Moderate-high vs low SLEDAI-2K: smaller thalamus volume
P = 0.005

Observational data: associations, not effects.

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

The impact of disease activity and interferon-α on the nervous system in systemic lupus erythematosus. Arthritis Res Ther. Published 20 March 2025. doi:10.1186/s13075-025-03539-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.